Vanguard Capital Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
HWM
Vanguard Capital Management's HCAT Position: Q2 2026 in Review
Vanguard Capital Management increased its Health Catalyst (HCAT) stake by 3% in Q2 2026, buying an estimated $124K and bringing the position to 2,971,598 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3055.
Vanguard Capital Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Vanguard Capital Management held 2,971,598 shares of Health Catalyst worth $5.91M as of Q2 2026.
- Vanguard Capital Management bought 85,945 Health Catalyst shares in Q2 2026, an estimated $124K.
- Health Catalyst made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3055 holding.
- Vanguard Capital Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.